Prescriber Certification of Requirements for Use of Paxlovid ((Nirmatrelvir Tablets; Ritonavir Tablets), Copackaged for Oral Use) - Washington

Prescriber Certification of Requirements for Use of Paxlovid ((Nirmatrelvir Tablets; Ritonavir Tablets), Copackaged for Oral Use) is a legal document that was released by the Washington State Department of Veterans Affairs - a government authority operating within Washington.

FAQ

Q: What is Paxlovid?
A: Paxlovid is a medication that contains two drugs, nirmatrelvir and ritonavir, and is used to treat COVID-19.

Q: What is the purpose of Prescriber Certification of Requirements for Use of Paxlovid?
A: The Prescriber Certification is required to ensure that Paxlovid is prescribed only to patients who meet specific criteria.

Q: Who can prescribe Paxlovid?
A: Only healthcare providers who have completed the Prescriber Certification process can prescribe Paxlovid.

Q: What are the requirements for prescribing Paxlovid?
A: Prescribers must complete the certification process and ensure that the patient meets specific criteria, such as being at high risk for severe illness from COVID-19 and having a positive COVID-19 test.

Q: Is Paxlovid available over the counter?
A: No, Paxlovid is a prescription medication and can only be obtained with a valid prescription from a healthcare provider.

Q: What are the possible side effects of Paxlovid?
A: Common side effects of Paxlovid may include diarrhea, rash, and nausea. It is important to discuss potential side effects with your healthcare provider.

Q: Can Paxlovid cure COVID-19?
A: While Paxlovid can help treat COVID-19, it is not a cure. It is important to continue following recommended guidelines such as vaccination and wearing masks to prevent the spread of the virus.